Jacqueline Lackey Selected Research

ASG-5ME

10/2019

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacqueline Lackey Research Topics

Disease

1	Hypoxia (Hypoxemia) 10/2019
1	Constipation 10/2019
1	Diarrhea 10/2019
1	Exanthema (Rash) 10/2019
1	Fatigue 10/2019
1	Hyponatremia 10/2019
1	Neutropenia 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 10/2019
1	Abdominal Pain (Pain, Abdominal) 10/2019

Drug/Important Bio-Agent (IBA)

1	monomethyl auristatin EIBA 10/2019
1	auristatinIBA 10/2019
1	ASG-5MEIBA 10/2019
1	TroponinIBA 10/2019
1	Immunoconjugates (Immunoconjugate)IBA 10/2019

Therapy/Procedure

1	Castration 10/2019